Rituximab for the Treatment of Primary Membranous Nephropathy: CADTH Health Technology Review [Internet]
Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr.
CADTH Health Technology Review.
Authors
Authors
;
Saadul Islam
,
Ghayath Janoudi
,
Matthew Bryan
,
Christine Perras
,
Mohammed Jabr
,
Alex Haines
,
Nazila Assasi
,
Julie Boucher
,
Deba Hafizi
,
Phil Lafleur
,
Cody Black
,
Tessa Cornelissen,
,
Caitlyn Ford
PMID:
38232188
Bookshelf ID:
NBK598994
No abstract available
Copyright © 2022 Canadian Agency for Drugs and Technologies in Health.
Publication types
Review